13 Results for "

BMK

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "BMK" in MCE Product Catalog:

17
17 Publications Verification
Cat. No.: HY-14443
CAS No.: 1234480-50-2
Purity:  99.48%
Research Areas:  

Cancer

XMD8-92 is a potent ERK5 (BMK1)/BRD4 inhibitor with Kds of 80 and 190 nM, respectively. XMD8-92 inhibits DCAMKL2, PLK4 and TNK1 with Kds of 190, 600 and 890 nM, respectively. Anti-cancer activity .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-18314
CAS No.: 504433-23-2
Target:  

Trk Receptor Apoptosis

Research Areas:  

Neurological Disease Cancer

GW 441756 is a potent and specific nerve growth factor (NGF) receptor tyrosine kinases A (TrkA) inhibitor (IC50=2 nM), which eliminates the BmK NSPK-induced neurite outgrowth .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-120079
CAS No.: 1592908-16-1
Purity:  99.00%
Target:  

Bcl-2 Family Apoptosis

Research Areas:  

Cancer

MSN-125 is a potent Bax and Bak oligomerization inhibitor. MSN-125 prevents mitochondrial outer membrane permeabilization (MOMP) with an IC50 of 4 μM. MSN-125 potently inhibits Bax/Bak-mediated apoptosis in HCT-116, BMK Cells, and primary cortical neurons, protects primary neurons against glutamate excitotoxicity .
loading...
    loading...
Cat. No.: HY-P5816
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

BmK-M1 is a scorpion toxin, and is composed of 64 amino acids cross-linked by four disulfide bridges. BmK-M1 inhibits Na + channel and can be considered both as a cardiotoxin and a neurotoxin .
loading...
    loading...
Cat. No.: HY-188159
CAS No.: 1314096-69-9
Target:  

CDK Apoptosis

Research Areas:  

Cancer

BMK-Y101 is a potent CDK kinase inhibitor. BMK-Y101 induces tumor cell apoptosis by inhibiting CDK kinases. BMK-Y101 can be used for research on hepatocellular carcinoma .
loading...
    loading...
Cat. No.: HY-RS16876
Research Areas:  

Others

Hck Mouse Pre-designed siRNA Set A contains three designed siRNAs for Hck gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P84530
Synonyms: BMK1; ERK4; ERK5; PRKM7

Host:  

Mouse

Application:  

IHC-P, ELISA

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P80122
Synonyms: BMK1, ERK5, PRKM7, MAPK7, Mitogen-activated protein kinase 7, MAP kinase 7, MAPK 7, Big MAP kinase 1, Extracellular signal-regulated kinase 5, BMK-1, ERK-5

Host:  

Rabbit

Application:  

WB, ICC/IF, IP, FC

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-P85724
Synonyms: BMK1, ERK5, PRKM7, MAPK7, Mitogen-activated protein kinase 7, MAP kinase 7, MAPK 7, Big MAP kinase 1, Extracellular signal-regulated kinase 5, BMK-1, ERK-5

Host:  

Mouse

Application:  

IHC-P, WB

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P84530A
Synonyms: BMK1; ERK4; ERK5; PRKM7

Host:  

Mouse

Application:  

IHC-P, ELISA

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P703179
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: MAPK7; BMK1 Kinase; Prev. PRKM7; BMK-1; BMK1; ERK-5; ERK5; Extracellular Signal-Regulated Kinase 5; Extracellular-Signal-Regulated Kinase 5; Mitogen-Activated Protein Kinase; Big MAP Kinase 1; ERK4; MAP Kinase 7; Mitogen-Activated Protein Kinase 7; MAPK 7
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P86354
Synonyms: MAPK7; BMK1; ERK5; PRKM7; Mitogen-activated protein kinase 7; MAP kinase 7; MAPK 7; Big MAP kinase 1; BMK-1; Extracellular signal-regulated kinase 5; ERK-5

Host:  

Rabbit

Application:  

WB, ICC/IF, IP, ELISA

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-116054
CAS No.: 1314096-68-8
Ibulocydine is an isobutyrate prodrug of the Cdk inhibitor BMK-Y101 (HY-188159), with oral activity, and exhibits IC50 values of approximately 50 nM against CDK1/CDK2, 530 nM against CDK7/cyclin H/Mat1, and 85 nM against CDK9/cyclin T. Ibulocydine reduces the phosphorylation levels of Rb, nucleolin, and RNA polymerase II CTD Ser-5 and Ser-2, downregulates the expression of Mcl-1, survivin, and XIAP, decreases MMP-9 expression, and lowers the Bcl-2/Bax ratio, activates calpain-mediated Bax cleavage, cytochrome c release, and caspase activation. Ibulocydine induces apoptosis, inhibits the growth of cancer cells and xenografts, enhances the sensitivity of cancer cells to TRAIL and radiotherapy, and blocks cancer cell metastasis. Ibulocydine can be used in research related to various cancers, including hepatocellular carcinoma, triple-negative breast cancer, lung cancer, and colon cancer .
loading...
    loading...
  • 1